...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke
【24h】

Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke

机译:缺血性卒中血浆组织纤溶酶原激活物,纤溶酶原激活物抑制物-1和β-血球蛋白含量的动态变化

获取原文
获取原文并翻译 | 示例

摘要

The aim of this paper is to investigate the corresponding variations of plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) activities, and beta thromboglobulin (beta-TG) content in patients during different stages of ischemic stroke. Ischemic stroke is a common disease among aging people and its occurrence is associated with abnormalities in the fibrinolytic system and platelet function. However, few reports focus on the dynamic changes in the plasma fibrinolytic system and beta-TG content in patients with ischemic stroke. Patients were divided into three groups: acute, convalescent and chronic. Plasma t-PA and PAI-1 activities were determined by chromogenic substrate analysis and plasma beta-TG content was detected by radioimmunoassay. Patients in the acute stage of ischemic stroke had significantly increased levels of t-PA activity and beta-TG content, but PAI-1 activity was significantly decreased. Negative correlations were found between plasma t-PA and PAI-1 activities and between plasma t-PA activity and beta-TG content in patients with acute ischemic stroke. There were significant differences in plasma t-PA and PAI-1 activities in the aged control group, as well as in the acute, convalescent and chronic groups. It can be speculated that the increased activity of t-PA in patients during the acute stage was the result of compensatory function, and that the increase in plasma beta-TG level not only implies the presence of ischemic stroke but is likely a cause of ischemic stroke. During the later stages of ischemic stroke, greater attention is required in monitoring levels of PAI-1. (C) 2015 Elsevier Ltd. All rights reserved.
机译:本文旨在研究不同缺血阶段患者血浆组织纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂1(PAI-1)活性以及β血球蛋白(β-TG)含量的相应变化中风。缺血性中风是老年人的常见疾病,其发生与纤溶系统和血小板功能异常有关。然而,很少有报道关注缺血性中风患者血浆纤溶系统的动态变化和β-TG含量。患者分为三组:急性,恢复期和慢性。通过生色底物分析测定血浆t-PA和PAI-1活性,并通过放射免疫测定法检测血浆β-TG含量。处于缺血性卒中急性期的患者的t-PA活性和β-TG含量显着增加,但PAI-1活性显着降低。急性缺血性卒中患者血浆t-PA和PAI-1活性之间以及血浆t-PA活性和β-TG含量之间呈负相关。老年对照组以及急性,恢复期和慢性组的血浆t-PA和PAI-1活性存在显着差异。可以推测,急性期患者中t-PA活性的增加是代偿功能的结果,血浆β-TG水平的升高不仅暗示缺血性中风的存在,而且可能是缺血的原因中风。在缺血性卒中的后期,监测PAI-1水平需要更多的关注。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号